Explained: What is RLF-100 or Aviptadil, the 1970 drug being explored for Covid-19 treatment
Red Book
Red Book

Pre-cum-Mains GS Foundation Program for UPSC 2026 | Starting from 5th Dec. 2024 Click Here for more information

News: An old drug formulation RLF-100 or Aviptadil is being probed to treat Covid-19 patients after initial studies have shown that the drug is able to halt SARS-CoV-2 virus replication in lungs.

Facts:

  • RLF-100 or Aviptadil: It is an old proprietary drug formulation of synthetic human Vasoactive Intestinal Polypeptide(VIP).

Additional Facts:

  • Vasoactive Intestinal Polypeptide (VIP): It is released throughout the body but remains mostly concentrated in lungs.
  • Significance of VIP:
    • It is produced by immune cells and nerve endings and acts as a neurotransmitter.
    • It helps improve muscle activity and blood flow in the gastrointestinal tract.
    • It has anti-inflammatory and anti-cytokine activity properties that can help in alleviating respiratory distress in COVID19 patients.

Discover more from Free UPSC IAS Preparation For Aspirants

Subscribe to get the latest posts sent to your email.

Print Friendly and PDF
Blog
Academy
Community